FDA药品中心主任谈糖尿病药物二甲双胍中杂质问题
2019.12.05
Statement from Janet Woodcock, M.D., director of FDA’s Center for Drug Evaluation and Research, on impurities found in diabetes drugs outside the U.S.
FDA药品中心主任Janet Woodcock博士就美国以外地区的糖尿病药物中发现的杂质发表声明
For Immediate Rele...
|